Proïnova V A, Pershin G N, Shashkina L F, Golubeva M I
Farmakol Toksikol. 1978 Jan-Feb;41(1):109-14.
Results of testing the embryotropic activity of bonaphthone used in different doses (700; 400; 100; 50 and 2 mg/kg) are reported. With its oral introduction to pregnant rats bonaphthone, given in doses at the level of the therapeutid one (2 mg/kg) and exceeding it by as much as 25 times (50 mg/kg), was found not to produce any damaging effect on the fetus. With its action in doses of 100 and 400 mg/kg a slight embryotoxic effect was noted. In the sublethal dose of 700 mg/kg the preparation displays a moderate embryotoxic action and produces a number of circulatory changes in the fetuses. It is concluded that bonaphthone displays no teratogenic properties.
报告了测试不同剂量(700、400、100、50和2毫克/千克)的萘普生胚胎otropic活性的结果。当给怀孕大鼠口服萘普生时,发现以治疗剂量水平(2毫克/千克)给药以及超过该剂量25倍(50毫克/千克)时,对胎儿没有产生任何损害作用。当以100和400毫克/千克的剂量作用时,观察到轻微的胚胎毒性作用。在700毫克/千克的亚致死剂量下,该制剂表现出中度的胚胎毒性作用,并在胎儿中产生一些循环系统变化。得出的结论是,萘普生没有致畸特性。